Optimal cut-off of homeostasis model assessment of insulin resistance (HOMA-IR) for the diagnosis of metabolic syndrome: Third national surveillance of risk factors of non-communicable diseases in Iran (SuRFNCD-2007)

Nutrition and Metabolism

Volumn 7, Issue , 2010, Pages

  Esteghamati, Alireza ^a   Ashraf, Haleh ^b   Khalilzadeh, Omid ^a   Zandieh, Ali ^a   Nakhjavani, Manouchehr ^a   Rashidi, Armin ^a   Haghazali, Mehrdad ^c   Asgari, Fereshteh ^c  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANALYTIC METHOD; ARTICLE; DIABETES MELLITUS; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INSULIN RESISTANCE; IRAN; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; RECEIVER OPERATING CHARACTERISTIC; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; YOUDEN INDEX;

EID: 77950668360     PISSN: None     EISSN: 17437075     Source Type: Journal    
DOI: 10.1186/1743-7075-7-26     Document Type: Article

References (41)

1. Role of glucose and insulin resistance in development of type 2 diabetes mellitus: results of a 25-year follow-up study. BC Martin JH Warram AS Krolewski RN Bergman JS Soeldner CR Kahn, Lancet 1992 340 925 929 10.1016/0140-6736(92) 92814-V 1357346
2. Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. AJ Hanley K Williams MP Stern SM Haffner, Diabetes Care 2002 25 1177 1184 10.2337/diacare.25.7.1177 12087016 (Pubitemid 41071169)
3. Insulin resistance, the metabolic syndrome, and incident cardiovascular events in the Framingham Offspring Study. MK Rutter JB Meigs LM Sullivan RB D'Agostino Sr PW Wilson, Diabetes 2005 54 3252 3257 10.2337/diabetes.54.11.3252 16249452
4. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. DR Matthews JP Hosker AS Rudenski BA Naylor DF Treacher RC Turner, Diabetologia 1985 28 412 419 10.1007/BF00280883 3899825 (Pubitemid 15018832)
5. Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. E Bonora G Targher M Alberiche RC Bonadonna F Saggiani MB Zenere T Monauni M Muggeo, Diabetes Care 2000 23 1 57 63 10.2337/diacare.23.1.57 10857969 (Pubitemid 30022895)
6. Relation between insulin resistance and carotid intima-media thickness and stenosis in nondiabetic subjects. Results from a cross-sectional study in Malmo. Sweden. B Hedblad P Nilsson L Janzon G Berglund, Diabet Med 2000 17 299 307 10.1046/j.1464-5491.2000.00280.x 10821297 (Pubitemid 30266125)
7. Níveis de insulina e HOMA em uma amostra da cidade do Rio de Janeiro. Estudo do Rio de Janeiro. R Pozzan R Pozzan AA Brando MEC Magalhes AP Brando, Rev Socerj 2003 16 75 75
8. Distribution of HOMA-IR in brazilian subjects with different body mass indexes. MT Ghiringhello JG Vieira TT Tachibana C Ferrer RM Maciel PH Amioka OM Hauache CH de Oliveira C Khawali AF Reis, Arq Bras Endocrinol Metab 2006 50 573 574 10.1590/S0004-27302006000300025 (Pubitemid 44298538)
9. The threshold value for insulin resistance (HOMA-IR) in an admixtured population IR in the Brazilian Metabolic Syndrome Study. B Geloneze EM Repetto SR Geloneze MA Tambascia MN Ermetice, Diabetes Res Clin Pract 2006 72 219 220 10.1016/j.diabres.2005.10.017 16310881
10. Optimal threshold of homeostasis model assessment for insulin resistance in an Iranian population: The implication of metabolic syndrome to detect insulin resistance. A Esteghamati H Ashraf AR Esteghamati A Meysamie O Khalilzadeh M Nakhjavani M Abbasi, Diabetes Res Clin Pract 2009 84 279 287 10.1016/j.diabres.2009.03.005 19359063
11. Cutoff values of surrogate measures of insulin resistance for metabolic syndrome in korean non-diabetic adults. S Lee S Choi HJ Kim YS Chung KW Lee HC Lee KB Huh DJ Kim, J Korean Med Sci 2006 21 695 700 10.3346/jkms.2006.21.4.695 16891815 (Pubitemid 44199326)
12. Relationship between several surrogate estimates o f insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. H Yeni-Komshian M Carantoni F Abbasi GM Reaven, Diabetes Care 2000 23 171 175 10.2337/diacare.23.2.171 10868826 (Pubitemid 30071019)
13. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. E Bonora S Kiechl J Willeit F Oberhollenzer G Egger G Targher M Alberiche RC Bonadonna M M, Diabetes 1998 47 1643 1649 10.2337/diabetes.47.10.1643 9753305 (Pubitemid 28445355)
14. The threshold value for insulin resistance on homeostasis model assessment of insulin sensitivity. Y Nakai M Fukushima S Nakaishi H Kishimoto Y Seino S Nagasaka M Sakai A Taniguchi, Diabet Med 2002 19 344 348 10.1046/j.1464-5491.2002.00712-3.x 11943010 (Pubitemid 34592164)
15. Homeostatic Model Assessment (HOMA) index cut-off values to identify the metabolic syndrome in children. B Tresaco G Bueno I Pineda LA Moreno JM Garagorri M Bueno, J Physiol Biochem 2005 61 381 388 10.1007/BF03167055 16180336 (Pubitemid 41269262)
16. Determinacián del índice de resistencia insulínica mediante HOMA en una poblacián de la regián metropolitana de Chile. B Acosta MO Escalona AG Maiz FC Pollak FP Leighton, Rev Med Chile 2002 130 1227 1231 12587504
17. Cuantificacián de insulinoresistencia con los valores de insulina basal e índice HOMA en una poblacián no diabética. JF Ascaso P Romero JT Real A Priego C Valdecabres R Carmena, Med Clin 2001 117 530 533
18. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. M Keskin S Kurtoglu M Kendirci ME Atabek C Yazici, Pediatrics 2005 115 500 503 10.1542/peds.2004-1921
19. Relationship to insulin resistance of the Adult Treatment Panel III diagnostic criteria for identification of the metabolic syndrome. KL Cheal F Abbasi C Lamendola T McLaughlin GM Reaven ES Ford, Diabetes 2004 53 1195 1200 10.2337/diabetes.53.5.1195 15111486 (Pubitemid 38569003)
20. Identification of subjects with insulin resistance and -cell dysfunction using alternative definitions of the metabolic syndrome. AJ Hanley LE Wagenknecht RB D'Agostino Jr B Zinman SM Haffner, Diabetes 2003 52 2740 2747 10.2337/diabetes.52.11.2740 14578292 (Pubitemid 37339703)
21. Third national surveillance of risk factors of non-communicable diseases (SuRFNCD-2007) in Iran: methods and results on prevalence of diabetes, hypertension, obesity, central obesity, and dyslipidemia. A Esteghamati A Meysamie O Khalilzadeh A Rashidi M Haghazali F Asgari M Kamgar MM Gouya M Abbasi, BMC Public Health 2009 9 167 10.1186/1471-2458-9-167 19480675
22. STEPwise approach to surveillance (STEPS). WHO, http://www.who.int/chp/ steps/en/ Accessed: 1 Sep, 2009
23. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. A Esteghamati MM Gouya M Abbasi A Delavari S Alikhani F Alaedini A Safaie M Forouzanfar EW Gregg, Diabetes Care 2008 31 1 96 98 10.2337/dc07-0959 17921357 (Pubitemid 351733363)
24. Estimation of the concentration of lowdensity lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. WT Friedewald RI Levy DS Fredrickson, Clinical Chemistry 1972 18 499 501 4337382
25. Diagnosis and Management of the Metabolic Syndrome An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. SM Grundy JI Cleeman SR Daniels KA Donato RH Eckel BA Franklin DJ Gordon RM Krauss PJ Savage SC Smith Jr JA Spertus F Costa, Circulation 2005 112 2735 2752 10.1161/CIRCULATIONAHA.105.169404 16157765 (Pubitemid 41532612)
26. International Diabetes Federation. The IDF consensus worldwide definition of the metabolic syndrome [article online]. 2006 http://www.idf.org/webdata/ docs/IDF-Meta-def-final.pdf Accessed Sep 1, 2009
27. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
28. Optimal waist circumference cut-offs for the diagnosis of metabolic syndrome in Iranian adults: results of the third national survey of risk factors of non-communicable diseases (SuRFNCD-2007). A Esteghamati M Abbasi A Rashidi A Meysamie O Khalilzadeh M Haghazali F Asgari M Nakhjavani, Diabet Med 2009 26 7 745 746 10.1111/j.1464-5491.2009.02756.x 19573127
29. The Statistical Evaluation of Medical Tests for Classification and Prediction. M Pepe, New York: Oxford University Press 2003
30. The inconsistency of "optimal" cutpoints obtained using two criteria based on the receiver operating characteristic curve. NJ Perkins EF Schisterman, Am J Epidemiol 2006 163 7 670 675 10.1093/aje/kwj063 16410346
31. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. E Bonora S Kiechl J Willeit F Oberhollenzer G Egger RC Bonadonna M Muggeo, Int J Obes Relat Metab Disord 2003 27 1283 1289 10.1038/sj.ijo.0802381 14513078 (Pubitemid 37281677)
32. Use and abuse of HOMA modeling. TM Wallace JC Levy DR Matthews, Diabetes Care 2004 27 6 1487 1495 10.2337/diacare.27.6.1487 15161807
33. Comparative evaluation of simple indices of insulin resistance. O Vaccaro M Masulli V Cuomo AA Rivellese M Uusitupa B Vessby, et al. Metabolism 2004 53 1522 1526 10.1016/j.metabol.2004.05.017 15562393 (Pubitemid 39556363)
34. Glucose intolerance of aging evidence for tissue insensitivity to insulin. RA Defronzo, Diabetes 1979 28 1095 1101 510806 (Pubitemid 10215014)
35. Relationship between glucose intolerance, insulin secretion, and insulin action in non obese individuals with varying degrees of glucose intolerance. GM Reaven CB Hollenbeck YD Chen, Diabetologia 1989 32 52 55 10.1007/BF00265404 2651188
36. Beyond type 2 diabetes: the need for a clinically useful way to identify insulin resistance. TL McLaughlin GM Reaven, Am J Med 2003 114 501 502 10.1016/S0002-9343(03)00122-0 12727584
37. Ethnic differences in the ability of triglyceride levels to identify insulin resistance. AE Sumner CC Cowie, Atherosclerosis 2008 196 696 703 10.1016/j.atherosclerosis.2006.12.018 17254586
38. Correspondence between the Adult Treatment Panel III criteria for metabolic syndrome and insulin resistance. J Sierra-Johnson BD Johnson TG Allison KR Bailey GL Schwartz ST Turner, Diabetes Care 2006 29 668 672 10.2337/diacare.29.03.06.dc05-0970 16505524 (Pubitemid 44115371)
39. The European Group for the Study of Insulin Resistance (EGIR) Comment on the provisional report from the WHO consultation. B Balkau MA Charles, Diabet Med 1999 16 442 443 10.1046/j.1464-5491.1999.00059.x 10342346
40. Epidemiology, trends, and morbidities of obesity and the metabolic syndrome. GA Bray T Bellanger, Endocrine 2006 29 109 117 10.1385/ENDO:29:1:109 16622298 (Pubitemid 43780352)
41. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 1997 106 3143 3421